Prognostic value of Ki67 (A), MCM4 (B), TYMS (C), and combined score (D), on recurrence-free interval (RFI) in the IHC validation cohort.

Gespeichert in:
Bibliographische Detailangaben
Titel: Prognostic value of Ki67 (A), MCM4 (B), TYMS (C), and combined score (D), on recurrence-free interval (RFI) in the IHC validation cohort.
Autoren: Annette Salomonsson, Daniel Ehinger, Mats Jönsson, Johan Botling, Patrick Micke, Hans Brunnström, Johan Staaf, Maria Planck
Publikationsjahr: 2025
Schlagwörter: Medicine, Cell Biology, Genetics, Biotechnology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, technique universally applicable, guide treatment choices, independent prognostic ability, concept study demonstrates, six data sets, selected markers could, potential prognostic markers, prognostic potential, data sets, prognostic markers, two independent, six microarray, tyms <, subsequent evaluation, patient surveillance, overall survival, mcm4 <, lung cancer
Beschreibung: Prognostic value of Ki67 (A), MCM4 (B), TYMS (C), and combined score (D), on recurrence-free interval (RFI) in the IHC validation cohort.
Publikationsart: article in journal/newspaper
Sprache: unknown
DOI: 10.1371/journal.pone.0310232.s007
Verfügbarkeit: https://doi.org/10.1371/journal.pone.0310232.s007
https://figshare.com/articles/journal_contribution/Prognostic_value_of_Ki67_A_MCM4_B_TYMS_C_and_combined_score_D_on_recurrence-free_interval_RFI_in_the_IHC_validation_cohort_/28948407
Rights: CC BY 4.0
Dokumentencode: edsbas.7E65FFB0
Datenbank: BASE
Beschreibung
Abstract:Prognostic value of Ki67 (A), MCM4 (B), TYMS (C), and combined score (D), on recurrence-free interval (RFI) in the IHC validation cohort.
DOI:10.1371/journal.pone.0310232.s007